Matrix-metalloproteinases and their inhibitors in plasma and tumor tissue of patients with renal cell carcinoma

International Journal of Cancer

Volumn 85, Issue 6, 2000, Pages 801-804

  Lein, Michael ^a   Jung, Klaus ^a   Laube, Christian ^a   Hübner, Tobias ^a   Winkelmann, Bjoern ^a   Stephan, Carsten ^a   Hauptmann, Steffen ^a   Rudolph, Birgit ^a   Schnorr, Dietmar ^a   Loening, Stefan A ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; ENZYME ANALYSIS; ENZYME LOCALIZATION; FEMALE; HUMAN; HUMAN TISSUE; KIDNEY CARCINOMA; MALE; PRIORITY JOURNAL; TISSUE DISTRIBUTION;

EID: 0034099066     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(20000315)85:6<801::AID-IJC11>3.0.CO;2-C     Document Type: Article

References (22)

1. ANDERSON, I.C., SUGARBAKER, D.J., GANJU, R.K., TSARWHAS, D.G., RICHARDS, W.G., SUNDAY, M., KOBZIK, L. and SHIPP, M.A., Stromelysin-3 is overexpressed by stromal elements in primary non-small cell lung cancers and regulated by retinoic acid in pulmonary fibroblasts. Cancer Res., 55, 4120-4126 (1995).
2. DAVIES, B., MILES, D.W., HAPPERFIELD, L.C., NAYLOR, M.S., BOBROW, L.G., RUBENS, R.D. and BALKWILL, F.R., Activity of type IV collagenases in benign and malignant breast disease. Brit. J. Cancer, 67, 1126-1131 (1993).
3. DUNN, M.J., Determination of total protein concentration. In: E.L.V. Harris and S. Angal (eds.), Protein purification methods, pp. 10-18, IRL Press, Oxford (1992).
4. GOESSL, C., HEICAPPELL, R., MUNKER, R., ANKER, P., STROUN, M., KRAUSE, H., MULLER, M. and MILLER, K., Microsatellite analysis of plasma DNA from patients with clear cell renal carcinoma. Cancer Res., 58, 4728-4732 (1998).
5. GOHJI, K., FUJIMOTO, N., FUJII, A., KOMIYAMA, T., OKAWA, J. and NAKAJIMA, M., Prognostic significance of circulating MMP2 to TIMP2 ratio in recurrence of urothelial cancer after complete resection. Cancer Res., 56, 3196-3198 (1996).
6. GOHJI, K., NOMI, M., HARA, I., ARAKAWA, S. and KAMIDONO, S., Influence of cytokines and growth factors on matrix-metalloproteinase-2 production and invasion of human renal cancer. Urol. Res., 26, 33-37 (1998).
7. JUNG, K., LAUBE, C., LEIN, M., LICHTINGHAGEN, R., TSCHESCHE, H., SCHNORR, D. and LOENING, S.A., Kind of sample as preanalytical determinant of matrix metalloproteinase 2 and 9 (MMP2;MMP9) and tissue inhibitor of metalloproteinase 2 (TIMP2) in blood. Clin. Chem., 44, 1060-1062 (1998a).
8. JUNG, K., LEIN, M., ULBRICH, N., RUDOLPH, B., HENKE, W., SCHNORR, D. and LOENING, S.A., Quantification of matrix metalloproteinases in and tissue inhibitors of metalloproteinase in prostatic tissue: analytical aspects. Prostate, 34, 130-136 (1998b).
9. KUGLER, A., HEMMERLEIN, B., THELEN, P., KALLERHOFF, M., RADZUN, H.J. and RINGERT, R.H., Expression of metalloproteinase 2 and 9 and their inhibitors in renal cell carcinoma. J. Urol., 160, 1914-1918 (1998).
10. LABARCA, C. and PAIGEN, K., A SIMPLE, RAPID, and SENSITIVE DNA ASSAY PROCEDURE. Analyt. Biochem., 102, 344-352 (1980).
11. LANDIS, S.H., MURRAY, T., BOLDEN, S. and WINGO, P.A., Cancer statistics, 1999. CA Cancer J. Clin., 49, 8-31 (1999).
12. LIOTTA, L.A. and STETLER-STEVENSON, W.G., Tumor invasion and metastasis: an imbalance of positive and negative regulation. Cancer Res., 51, 5054-5059 (1991).
13. LIUNGBERG, B., RASMUSON, T. and GRANKVIST, K., Erythropoietin in renal cell carcinoma: evaluation of its usefulness as a tumor marker. Europ. Urol., 21, 160-163 (1992).
14. LOKESHWAR, B.L., SELZER, M.G., BLOCK, N.L. and GUNJA-SMITH, Z., Secretion of matrix metalloproteinases and their inhibitors (tissue inhibitors of metalloproteinases) by human prostate explant cultures: reduced tissue inhibitor of metalloproteinase secretion by malignant tissues. Cancer Res., 53, 4493-4498 (1993).
15. MIYAKE, H., HARA, I., YOSHIMURA, K., ETO, H., ARAKAWA, S., WADA, S., CHIHARA, K. and KAMIDONO, S., Introduction of basic fibroblast growth factor gene into a mouse renal cell carcinoma cell line enhances its metastatic potential. Cancer Res., 56, 2440-2445 (1996).
16. MURRAY, G.I., DUNCAN, M.E., O'NEIL, P., MELVIN, W.T. and FOTHERGILL, J.E., Matrix metalloproteinase-1 is associated with poor prognosis in colorectal cancer. Nature (Med.), 2, 461-462 (1996).
17. OZEN, H., UYGUR, C., SAHIN, A., TEKGUL, S., ERGEN, A. and REMZI, D., Clinical significance of serum ferritin in patients with renal cell carcinoma. Urology, 46, 494-498 (1995).
18. PRINCE, J.T., WILSON, H.M. and HAITES, N.E., Epidermal growth factor (EGF) increases the in vitro invasion, motility and adhesion interactions of the primary renal carcinoma cell line, A704. Europ. J. Cancer, 11, 1977-1982 (1996).
19. RAY, J.M. and STETLER-STEVENSON, W.G., The role of matrix metalloproteinases and their inhibitors in tumor invasion, metastasis and angiogenesis. Europ. Respir. J., 7, 2062-2072 (1994).
20. SOBIN, L.H. and WITTEKIND, C. (EDS.), TNM classification of malignant tumours (5th ed.), pp. 171-173, Wiley-Liss, New York (1997).
21. WALTHER, M.M., KLEINER, D.E., LUBENSKY, I.A., POZZATTI, R., NYGUEN, T., GNARRA, J.R., HURLEY, K., VENZON, D., LINEHAN, W.M. and STETLER-STEVENSON, W.G., Progelatinase A mRNA expression in cell lines derived from tumors in patients with metastatic renal cell carcinoma correlates inversely with survival. Urology, 50, 295-301 (1997).
22. ZUCKER, S., LYSIK, R.M., DIMASSIMO, B.I., ZARRABI, H.M., MOLL, U.M., GRIMSON, R., TICKLE, S.P. and DOCHERTY, A.J., Plasma assay of gelatinase B: tissue inhibitor of metalloproteinase complexes in cancer. Cancer, 76, 700-708 (1995).